Correction to: Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT)

Hanna, Catherine R.; O’Cathail, Sean M.; Graham, Janet S.; Saunders, Mark; Samuel, Leslie; Harrison, Mark; Devlin, Lynsey; Edwards, Joanne; Gaya, Daniel R.; Kelly, Caroline A.; Lewsley, Liz-Anne; Maka, Noori; Morrison, Paula; Dinnett, Louise; Dillon, Susan; Gourlay, Jacqueline; Platt, Jonathan J.; Thomson, Fiona; Adams, Richard A.; Roxburgh, Campbell S. D.

doi:10.1186/s13014-021-01941-z

Correction to: Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT)

Correction
Open access
Published: 02 December 2021

Volume 16, article number 230, (2021)
Cite this article

Download PDF

You have full access to this open access article

Radiation Oncology Aims and scope Submit manuscript

Correction to: Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT)

Download PDF

1142 Accesses
Explore all metrics

The Original Article was published on 26 August 2021

Correction to: Radiat Oncol (2021) 16:163. https://doi.org/10.1186/s13014-021-01888-1

After publication of this article [1], the authors reported that the Funding information section was incomplete. The following should have been added: “This work was supported by CRUK (Grant Number C61974/A2429).”

The original article [1] has been updated.

Reference

Hanna CR, O’Cathail SM, Graham JS, et al. Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT). Radiat Oncol. 2021;16:163. https://doi.org/10.1186/s13014-021-01888-1.
Article CAS PubMed PubMed Central Google Scholar

Download references

Author information

Authors and Affiliations

Cancer Research UK Glasgow Clinical Trials Unit, Beatson West of Scotland Cancer Centre, Institute of Cancer Sciences, University of Glasgow, Level 0, 1053 Great Western Road, Glasgow, G12 0YN, UK
Catherine R. Hanna, Caroline A. Kelly, Liz-Anne Lewsley, Louise Dinnett, Susan Dillon & Jacqueline Gourlay
Beatson West of Scotland Cancer Centre, Institute of Cancer Sciences, University of Glasgow, 1053 Great Western Road, Glasgow, G12 0YN, UK
Sean M. O’Cathail & Janet S. Graham
Beatson West of Scotland Cancer Centre, 1053 Great Western Road, Glasgow, G12 0YN, UK
Lynsey Devlin
The Christie NHS Foundation Trust, Wilmslow Rd, Manchester, M20 4BX, UK
Mark Saunders
Aberdeen Royal Infirmary, Aberdeen, AB25 2ZN, UK
Leslie Samuel
Mount Vernon Cancer Centre, Rickmansworth Rd, Northwood, HA6 2RN, UK
Mark Harrison
Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Bearsden, G61 1QH, UK
Joanne Edwards
Gastroenterology Unit, Glasgow Royal Infirmary, NHS Greater Glasgow and Clyde, 4th Floor Walton Building, Castle Street, Glasgow, G4 0SF, UK
Daniel R. Gaya
Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde, 1345 Govan Road, Glasgow, G51 4TF, UK
Noori Maka
Snr Pharmacist Clinical Trials Oncology R&I, Research and Innovation, Dykebar Hospital, NHS Greater Glasgow and Clyde, Ward 11, Grahamston Road, Paisley, PA2 7DE, UK
Paula Morrison
Department of Radiology, NHS Greater Glasgow and Clyde, Glasgow Royal Infirmary, 84 Castle Street, Glasgow, G4 0SF, UK
Jonathan J. Platt
Institute of Cancer Sciences, University of Glasgow, Glasgow, G61 1QH, UK
Fiona Thomson
Centre for Trials Research Cardiff University Heath Park, Cardiff University and Velindre NHS Trust, Cardiff, UK
Richard A. Adams
Institute of Cancer Sciences, Glasgow Royal Infirmary, University of Glasgow, Room 2.57, Level 2, New Lister Building, Glasgow, G31 2ER, UK
Campbell S. D. Roxburgh

Authors

Catherine R. Hanna
View author publications
You can also search for this author in PubMed Google Scholar
Sean M. O’Cathail
View author publications
You can also search for this author in PubMed Google Scholar
Janet S. Graham
View author publications
You can also search for this author in PubMed Google Scholar
Mark Saunders
View author publications
You can also search for this author in PubMed Google Scholar
Leslie Samuel
View author publications
You can also search for this author in PubMed Google Scholar
Mark Harrison
View author publications
You can also search for this author in PubMed Google Scholar
Lynsey Devlin
View author publications
You can also search for this author in PubMed Google Scholar
Joanne Edwards
View author publications
You can also search for this author in PubMed Google Scholar
Daniel R. Gaya
View author publications
You can also search for this author in PubMed Google Scholar
Caroline A. Kelly
View author publications
You can also search for this author in PubMed Google Scholar
Liz-Anne Lewsley
View author publications
You can also search for this author in PubMed Google Scholar
Noori Maka
View author publications
You can also search for this author in PubMed Google Scholar
Paula Morrison
View author publications
You can also search for this author in PubMed Google Scholar
Louise Dinnett
View author publications
You can also search for this author in PubMed Google Scholar
Susan Dillon
View author publications
You can also search for this author in PubMed Google Scholar
Jacqueline Gourlay
View author publications
You can also search for this author in PubMed Google Scholar
Jonathan J. Platt
View author publications
You can also search for this author in PubMed Google Scholar
Fiona Thomson
View author publications
You can also search for this author in PubMed Google Scholar
Richard A. Adams
View author publications
You can also search for this author in PubMed Google Scholar
Campbell S. D. Roxburgh
View author publications
You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Catherine R. Hanna.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Cite this article

Hanna, C.R., O’Cathail, S.M., Graham, J.S. et al. Correction to: Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT). Radiat Oncol 16, 230 (2021). https://doi.org/10.1186/s13014-021-01941-z

Download citation

Published: 02 December 2021
DOI: https://doi.org/10.1186/s13014-021-01941-z

Correction to: Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT)

Correction to: Radiat Oncol (2021) 16:163. https://doi.org/10.1186/s13014-021-01888-1

Reference

Author information

Authors and Affiliations

Corresponding author

Additional information

Publisher's Note

Rights and permissions

About this article

Cite this article

Share this article

Search

Navigation